Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Aug 6, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Aug 6, 2026, 6:31 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $30.9 million as of August 6, 2026. Its market cap has decreased by -55.30% in one year.
Market Cap
30.90M
Enterprise Value
6.78M
1-Year Change
-55.30%
Ranking
Category
Stock Price
$1.31
ChartMarket Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $30.90M, a decrease of -85.20%. That is a compound annual growth rate of -33.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 30.90M | -11.48% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 33.91M |
| Lite Strategy | 32.13M |
| Serina Therapeutics | 32.09M |
| Estrella Immunopharma | 30.30M |
| Tevogen | 29.54M |
| Aligos Therapeutics | 29.39M |
| BriaCell Therapeutics | 29.13M |
| Kyntra Bio | 28.01M |